FDA Inspection 1195681 — Ablexan Corporation
The FDA completed an inspection of Ablexan Corporation on January 23, 2023 in Raleigh, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 23, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Raleigh, NC (United States)